Researchers at the University of California, Irvine have developed a multimodal, bioelectronic wrist-worn device for ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...

Angel School empowers the next generation of venture investors through angel investing courses, syndicate investment, and a ...

New studies show Apple Watch detects atrial fibrillation early, helping prevent strokes by identifying hidden heart ...

The website functions as a comprehensive discovery guide for watch enthusiasts and everyday consumers. Watch Store Co curates selections based on design, functionality, customer feedback, and overall ...

Two weeks after giving the nod to Imricor's novel ablation catheter, the FDA has cleared the company's overriding 'dashboard' ...

A new scientific statement provides clinicians with practical guidance on how to integrate digital health tools into everyday heart failure care - moving beyond isolated devices toward coordinated, ...

Coral Gables-based Baptist Health South Florida is incorporating data from consumer wearable devices into cardiology care, using continuous heart monitoring to help flag potential issues between ...

Smartwatch-based monitoring using both photoplethysmography and ECG could improve detection of new-onset atrial fibrillation ...

Northwestern University researchers have developed the first device that can continuously track a fetus's vital signs while still in the uterus - a feat that previously has not been possible.